Amniotic Membrane Global Market Report 2023
Major players in the amniotic membrane market are Alliqua BioMedical, Amnio Technology, Applied Biologics, Human Regenerative Technologies LLC, Rivela...
Source: globenewswire.com
📰 Tissue Inc News
Tissue Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tissue Inc. Real-time updates on events, politics, business and more.
Global Contact Lenses Marketplace 2023-2028: Soft Contact Lenses Continue to Dominate, Silicone Hydrogel (SiHy) Lenses Projected to Increase in Popularity
/PRNewswire/ -- The "Contact Lenses: Technologies and Global Markets" report has been added to ResearchAndMarkets.coms offering. The increasing prevalence of...
United States Alcona Novartis Essilor Luxottica Laura Wood Essilor International Shanghai Haohai Biological Technology Co
Source: prnewswire.com
Ophthalmic Devices Technologies and Global Markets Report
Dublin, March 02, 2023 (GLOBE NEWSWIRE) -- The "Ophthalmic Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's...
Source: globenewswire.com
Ophthalmic Device Global Market Report 2023: Launch of New Biocompatible Materials Bolsters Growth
/PRNewswire/ -- The "Ophthalmic Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.coms offering. In recent years there...
Source: prnewswire.com
TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain
TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain Investigators will evaluate the dosage and safety of Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord TTAX03 for pain relief and functional improvement of facet joint osteoarthritis in the lumbosacral region News provided by Share this article Share this article MIAMI, March 8, 2021 /PRNewswire/ -- Amniox Medical, Inc. (Amniox), ...
United States Amy Tseng Prnewswire Amniox Medical Inc Amniox Medical Inc Tissuetech Inc Drug Administration
Source: prnewswire.com
TissueTech Receives U.S. Food and Drug Administration Clearance to Proceed with Clinical Study using Investigational New Drug TTBT01
Share this article Share this article MIAMI, March 1, 2021 /PRNewswire/ -- Bio-Tissue, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today that its parent company TissueTech had received clearance from the U.S. Food and Drug Administration (FDA) to proceed with a Phase 2 study using morselized Cryopreserved Amniotic Membrane (CAM) and Cryopreserved Umbilical Cord (CUC) Investigational New Drug (IND) TTBT01. This clearan...
Source: prnewswire.com